84762-34-5 Usage
Uses
Used in Pharmaceutical Industry:
Piperacetam is used as a cognitive enhancer for improving memory, learning, and overall cognitive function. Its neuromodulatory effects on neurotransmitter systems and its ability to enhance cerebral blood flow contribute to its potential therapeutic use in various cognitive disorders.
Used in Neurological Applications:
In the field of neurology, piperacetam is used as a potential therapeutic agent for conditions such as Alzheimer's disease, epilepsy, and cognitive impairment. Its neuroprotective and cognitive-enhancing properties make it a promising candidate for further research and development in these areas.
Used in Research and Development:
Piperacetam is utilized in research settings to explore its mechanisms of action and potential therapeutic uses. As a nootropic, it provides a basis for understanding the effects of cognitive enhancers on neurotransmitter systems and cerebral blood flow, which can contribute to the development of new treatments for neurological and cognitive disorders.
Check Digit Verification of cas no
The CAS Registry Mumber 84762-34-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,4,7,6 and 2 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 84762-34:
(7*8)+(6*4)+(5*7)+(4*6)+(3*2)+(2*3)+(1*4)=155
155 % 10 = 5
So 84762-34-5 is a valid CAS Registry Number.
InChI:InChI=1/C11H19N3O2/c1-12-5-7-13(8-6-12)11(16)9-14-4-2-3-10(14)15/h2-9H2,1H3
84762-34-5Relevant academic research and scientific papers
POTENTIAL NOOTROPIC AGENTS: SYNTHESIS OF A SERIES OF (2-OXO-1-PYRROLIDINYL)ACETIC ACID PIPERAZIDES
Valenta, Vladimir,Sindelar, Karel,Holubek, Jiri,Ryska, Miroslav
, p. 1613 - 1629 (2007/10/02)
The title compounds VI-XXIII were prepared by heating ethyl (2-oxo-1-pyrrolidinyl)acetate (II) with a series of N-monosubstituted piperazines.The propionamides XXVI and XXX were obtained by reactions of the acid chlorides IV and XXXIII with 3-(1-piperazinyl)propionamide.Compounds VI (VUFB-13 763) and VIII (VUFB-14 745) proved more active than piracetam (I) by their antiamnestic effects in rats by antagonising the brain demaging effects of cycloheximide in infantile rats, and by their potentation of the effects of anticolvunsant agents.
